The honest answer is somewhere in between, and worth understanding clearly before assuming its either essential or irrelevant
Researchers use it as a comparator when studying newer compounds like Tirzepatide (dual agonist) and Retatrutide (triple agonist)
Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid
Semaglutide is the established standard with three FDA approvals, massive clinical evidence, and proven cardiovascular outcomes
Notably, the study did not mention an increased fracture risk associated with semaglutide, despite the fact that this information is currently reported elsewhere [80]
When it comes to administering semaglutide, a medication commonly used for weight loss and diabetes management, proper injection technique and site selection are crucial for effective treatment and patient comfort